# A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265

> **NCT02389348** · PHASE1,PHASE2 · COMPLETED · sponsor: **Medicines for Malaria Venture** · enrollment: 13 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** DSM265
- **DRUG:** OZ439

## Key facts

- **NCT ID:** NCT02389348
- **Lead sponsor:** Medicines for Malaria Venture
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2015-10-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02389348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02389348, "A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02389348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*